Rich Tapestry became Hong Kong's first winner on U.S. soil when he captured the Grade 1 Santa Anita Sprint Championship Oct. 4. The accomplishment was even more significant since the 6-year-old competed without the use of Furosemide (Lasix).
Off that sharp score, Rich Tapestry was installed as the favorite for the G1 Xpressbet Breeders' Cup Sprint last Saturday. However, the Michael Chang trainee never was in contention and finished last. An endoscopic exam performed after the race showed that Rich Tapestry had bled significantly.
Despite Rich Tapestry's poor performance in the Breeders' Cup, Hong Kong Jockey Club officials were certain that they made the right decision in dissuading Chang from running the gelding on Lasix for that race.
HKJC head of racing Bill Nader told the South China Morning Post, “We stand firm. We are a racing jurisdiction that doesn't believe in race day medication and we believe strongly in that. We believe that other jurisdictions should take the same line. The horse was still able to win without Lasix first-up.”
Read more in the South China Morning Post
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2019 Paulick Report.